Clinical Trial Participant 'Biogen's Aducanumab Was Working' | Patient Perspectives | Being Patient
Biogen has announced new data behind the Alzheimer's drug aducanumab suggests it was working on early stage patients. Jeff Borghoff was a participant for three years before the company halted the stage three clinical trial. He talks to Being Patient Alzheimer's about why he felt the drug was working.
Our mission is to give people impacted by dementia a better resource and connection to experts at the forefront of research. Our founder Deborah Kan funded Being Patient solely with her own savings to understand if people would value such a resource. Our audience has grown so rapidly, we have exciting plans for the future to enhance our coverage even further but we need your help. Please consider making a contribution to help fund Being Patient's editorial costs. We employ a team of journalists to give you the best possible information on dementia and brain health without bias.
To catch our Brain Talks live, join our Facebook page: https://www.facebook.com/beingpatientalzheimers/
For the latest news on dementia research and lifestyle tips, visit our site: https://www.beingpatient.com/
Видео Clinical Trial Participant 'Biogen's Aducanumab Was Working' | Patient Perspectives | Being Patient канала Being Patient Alzheimer's
Our mission is to give people impacted by dementia a better resource and connection to experts at the forefront of research. Our founder Deborah Kan funded Being Patient solely with her own savings to understand if people would value such a resource. Our audience has grown so rapidly, we have exciting plans for the future to enhance our coverage even further but we need your help. Please consider making a contribution to help fund Being Patient's editorial costs. We employ a team of journalists to give you the best possible information on dementia and brain health without bias.
To catch our Brain Talks live, join our Facebook page: https://www.facebook.com/beingpatientalzheimers/
For the latest news on dementia research and lifestyle tips, visit our site: https://www.beingpatient.com/
Видео Clinical Trial Participant 'Biogen's Aducanumab Was Working' | Patient Perspectives | Being Patient канала Being Patient Alzheimer's
Показать
Комментарии отсутствуют
Информация о видео
Другие видео канала
Analyzing the clinical data for Aduhelm, Biogen's controversial Alzheimer's drug
Extended Interview with Alzheimer's Patient, Don Hayen
Analyst: It's unclear whether Biogen's new Alzheimer's drug will get approved
Characteristics of Neurodegenerative Diseases and Advancements in Research
What Does an Alzheimer's Drug Relaunch Mean For A Cure? | Brain Talks | Being Patient
Finding Purpose After a Younger-Onset Alzheimer's Diagnosis | Patient Perspectives | Being Patient
Novo Medicamento Para Tratamento de Alzheimer: Aducanumab
Understanding Alzheimer’s Disease (AD)
ADUCANUMAB (Aduhelm) : uma mudança de paradigma no tratamento da Doença de Alzheimer.
Man With Lewy Body Dementia Misdiagnosed for Years | Patient Perspectives | Being Patient
‘Have You Heard About Greg?’ Filmmakers on Greg O’Brien’s Alzheimer’s Story | Being Patient
Improving the Diagnosis and Management of Lewy Body Dementia | Professor John O'Brien
Alzheimer’s or Not? Still Uncertain a Decade After Diagnosis | LiveTalk | Being Patient
Living with Younger Onset Alzheimer's: Firsthand Perspectives
CRO - Contract Research Organization (Clinical)
Dementia Caregiving and the Need For Paid Family Leave | LiveTalk | Being Patient
US approves first new Alzheimer's drug in 20 years - BBC News
A Grandmother’s Parkinson’s Battle, A Granddaughter’s Career Inspiration | LiveTalk | Being Patient
Tim Urban: Inside the mind of a master procrastinator | TED
Do Salt Lamps Work?